How AI is transforming biotech and pharma supply chains through demand planning, cold chain optimization, digital twins, and shortage prediction.
AI in CDMO selection and management: how to pick the right partner and hold them accountable More than 50% of global biotech drug manufacturing is handled by contract development and manufacturing organisations. For most biotech companies, the CDMO is the single most critical external dependency in their supply chain. A CDMO failure does not just […]
AI in pharmaceutical manufacturing quality: from reactive QC to predictive control Pharmaceutical manufacturing quality control has operated on the same fundamental model for decades. Collect samples at defined intervals. Test in the laboratory. Release or reject the batch. Wait 48 to 72 hours for results. AI is dismantling this model. Not incrementally. Structurally. Sanofi’s CEO
AI in pharmaceutical manufacturing quality: from reactive QC to predictive control Read More »
AI cold chain optimisation for biologics: how to stop losing product to temperature excursions A single temperature excursion on a biologic shipment can write off product worth hundreds of thousands of dollars. At scale, across a global distribution network, the losses are structural. The biologics cold chain has always been the most operationally complex part
More than 85% of biopharma executives are investing in AI supply chain tools in 2025. AI models analyse demand, logistics, and geopolitical signals in real time to reduce carrying costs, prevent stockouts, and accelerate time-to-market. One top-10 pharma company projects saving 1 billion dollars over five years through AI-driven optimisation.
How AI Is Cutting Supply Chain Costs Across Biotech Read More »
